FDA Drug Safety Communication: FDA warns about cases of rare brain infection with MS drug Gilenya (fingolimod) in two patients with no prior exposure to immunosuppressant drugs
US Food and Drug Administration, 4 Aug 2015
Accessed on 11 Aug 2015 from http://www.fda.gov/Drugs/DrugSafety/ucm456919.htm.